EP Patent

EP2395002A1 — Pharmaceutical composition containing a heterocyclic modulator of ATP-binding cassette transporters.

Assigned to Vertex Pharmaceuticals Inc · Expires 2011-12-14 · 14y expired

What this patent protects

Pharmaceutically acceptable compositions of the present invention are useful as modulators of ATP-Binding Cassette ("ABC") transporters of fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR").

USPTO Abstract

Pharmaceutically acceptable compositions of the present invention are useful as modulators of ATP-Binding Cassette ("ABC") transporters of fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR").

Drugs covered by this patent

Patent Metadata

Patent number
EP2395002A1
Jurisdiction
EP
Classification
—
Expires
2011-12-14
Drug substance claim
No
Drug product claim
No
Assignee
Vertex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.